Course: Are SARS-CoV-2 Human Challenge Trials Ethical?
CME Credits: 1.00
Released: 2021-06-07
A clinical trial is underway in the UK in which young, healthy participants are exposed deliberately to SARS-CoV-2 to assess the viral inoculum needed to produce an infection and to test vaccine efficacy (). Each participant will be paid approximately $6200. Although the very idea of such a study might seem unethical, there is a long history of deliberate infection of humans for research. Such studies are called challenge studies or controlled human infection trials and involve deliberate exposure to pathogens to study the natural history, treatment, or prevention of infectious diseases.
Educational Objective
To identify the key insights or developments described in this article
View Full Course